Dendritic Cells Pulsed with Hsp70 and HBxAg Induce Specific Antitumor Immune Responses in Hepatitis B Virus-associated Hepatocellular Carcinoma
Overview
Authors
Affiliations
Previous studies have drawn attention to dendritic cell (DC) vaccines; particularly the application of the tumor-associated antigen-targeted DC vaccine. The present study analyzed DCs derived from a normal individual and pulsed the cells with heat shock protein 70 peptide (Hsp70) and/or hepatitis B virus x antigen (HBxAg), a hepatocellular carcinoma (HCC)-associated antigen. It was then investigated whether this method of vaccination induced strong therapeutic antitumor immunity. The results revealed that the Hsp70/HBxAg complex-activated phenotype improves the functional maturation of DCs compared with using Hsp70 or HBxAg alone. Compared with either Hsp70 or HBxAg alone, matured DCs pulsed with the Hsp70/HBxAg complex stimulated a high level of autologous T-cell proliferation and induced HCC-specific cytotoxic T lymphocytes, which specifically killed HCC cells through a major histocompatibility complex class I mechanism. These results indicated that a vaccination therapy using DCs co-pulsed with the Hsp70/HBxAg complex is an effective strategy for immunotherapy and may offer a useful approach to protect against HCC.
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.
Khan M, Mao B, Hu J, Shi M, Wang S, Ur Rehman A Front Immunol. 2024; 15:1472430.
PMID: 39450177 PMC: 11499146. DOI: 10.3389/fimmu.2024.1472430.
Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy.
Chen Y, Tang S, Cai F, Wan Y Research (Wash D C). 2024; 7:0421.
PMID: 39040921 PMC: 11260559. DOI: 10.34133/research.0421.
de Beijer M, Jansen D, Dou Y, van Esch W, Mok J, Maas M J Virol. 2019; 94(7).
PMID: 31852786 PMC: 7081907. DOI: 10.1128/JVI.01663-19.
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Wang X, Wang Q Can J Gastroenterol Hepatol. 2018; 2018:9049252.
PMID: 29805966 PMC: 5899840. DOI: 10.1155/2018/9049252.